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A B S T R A C T
Prompt detection and identiﬁcation of fungal pathogens at the genus and species level is critical in order
to provide timely antifungal therapy. Here, we highlight the vital role of molecular diagnostics in
achieving a fast and deﬁnitive diagnosis of disseminated blastomycosis in a diabetic patient presenting
as a brain mass initially thought to be tumoral in nature. A broad-range PCR ampliﬁcation and
sequencing of the fungal ribosomal RNA genes on brain biopsy tissue obtained during elective
craniotomy revealed a ﬁnal microbial identiﬁcation of Ajellomyces dermatitidis (telemorph of Blastomyces
dermatitidis).
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A 73-year-old man presented to an outside hospital emergency
room in September 2014, with an episode of generalized tonic-
clonic seizures. The patient had a history of prostate cancer for
which he underwent a prostatectomy in 2000 followed by
radiation therapy in 2003, and deemed to be in remission at the
time of this presentation.
His physical examination was signiﬁcant for diminished
strength in the left upper extremity. He was admitted to the
hospital and a brain magnetic resonance (MR) was performed; it
showed a heterogeneously enhancing lesion in the right fronto-
parietal area with adjacent vasogenic edema. Based on this ﬁnding,
a primary or secondary malignancy was strongly considered and a
brain biopsy was advised. He was subsequently discharged on anti-
seizure medications and systemic steroids.
The patient then presented to our institution for a second
opinion. He was electively admitted to for a craniotomy and brain
biopsy. Intraoperative ﬁndings were suspicious for a grossly* Corresponding author. 1275 York Avenue Box 9, New York, NY, 10065.
E-mail address: ﬁgueroc@mskcc.org (C.J. Figueroa).
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1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).necrotic abscess that yielded 5-10 mL of non-foul-smelling,
purulent ﬂuid upon incision. This ﬂuid was evacuated and sent
to the pathology and microbiology laboratories for further testing.
The mass was not entirely resected given the critical location of the
lesion. Results of histopathology analysis of the brain tissue
obtained during biopsy were available ﬁrst. Analysis showed
necrotizing granulomatous inﬂammation containing degenerated
budding yeast forms (7-10 mm in diameter) that were highlighted
by periodic acid-Schiff stain (Figure 1A). The organisms stained
weakly for mucicarmin and Fontana-Masson, suggesting crypto-
coccal infection, which was the favored diagnosis at this time.
Parallel to the histopathology analysis, microbiological testing
took place. The initial Gram stain of the brain surgical biopsy
material showed 2+ polymorphonuclear neutrophils but no
microorganisms. A wet mount showed round, yeast-like organisms
lacking a capsule (Figure 1B).
Intraoperative cultures from the brain lesion remained negative
after 5 days of incubation and the decision was made to perform
broad-range fungal PCR ampliﬁcation from the original parafﬁ-
nated, brain biopsy tissue obtained during elective craniotomy. On
hospital day number 10, results from molecular testing became
available and PCR targeting both the internal transcribed spacer
region 2 (ITS2) and D2 regions of fungal ribosomal RNA locusciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. (A) Periodic acid-Schiff staining of the brain tissue highlighting fungal
forms of variables sizes in a necrotic background (B) Wet mount performed on brain
tissue from original brain biopsy denoting the lack of capsule and internal
structures. Scale bar = 20 mm.
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microbial identiﬁcation of Ajellomyces dermatitidis (telemorph of
Blastomyces dermatitidis). PCR ampliﬁcation and sequencing was
performed according to the previously published method.1 The
patient’s D2 sequence was 100% (289/289) identical to Ajellomyces
dermatitidis University of Alberta Microfungus Collection and
Herbarium (UAMH) 3604 strain and the ITS2 sequence was 100%
(349/349) identical to Ajellomyces dermatitidis strain UAMH 10592.
It was only after 13 days of incubation that cultures of the brain
aspirate, grown at 30 8C on brain-heart infusion agar (BHI) and
35 8C on blood agar, grew mycelial and yeast forms, respectively,
suggesting the presence of a dimorphic fungus. Due to its slow
growth, ﬁnal identiﬁcation of the causative microorganism
recovered from culture by morphological features only took place
on postoperative day twenty, conﬁrming the previously obtained
molecular diagnosis.
Serum antibody immunoﬁxation tests for Blastomyces and
Coccidioides were sent and yielded positive results but these
became available a week after molecular testing results were
known. Since there was no evidence of Coccidioides infection in the
histopathology or microbiology workup, these results were
deemed to be falsely positive.
The patient was treated with 8 weeks of intravenous liposomal
amphotericin B. While on this regimen, he had slow but
progressive improvement in the left body strength. A repeat brain
MR performed approximately 8 weeks after starting antifungal
therapy showed a decrease in the volume of his known brain
lesion.2. Discussion
The diagnosis of Blastomyces dermatitidis is challenging
and requires a high index of suspicion along with close
communication between clinicians and laboratory departments.
As described on a series by Lemos et al. blastomycosis was
correctly diagnosed on ﬁrst clinical impression in only 20% of
patients.2
Morphological fungal identiﬁcation from formalin-ﬁxed, paraf-
ﬁn embedded tissues has historically been a powerful tool in early
identiﬁcation of fungal pathogens. Its use is greatest when
accompanied by conﬁrmatory positive cultures; however, fungal
classiﬁcation by histologic analysis can be difﬁcult and prone to
error. Histopathological identiﬁcation is usually limited in its
ability to identify the causative organism to the genus and/or
species level. Sangoi et al. described the high incidence of
discrepant diagnoses between histopathology and culture meth-
ods, which can be as high as 21%. In their experience discrepant
results are not operator-dependent and are not affected by
morphologic overlap.3
More recently, molecular testing, including broad-range PCR
and sequencing have shown promise in the early diagnosis of
fungal infections. Fungal ribosomal RNA gene sequencing relies on
primer hybridization to highly conserved sequences and ampliﬁ-
cation of variable ﬂanking sequences. The ribosomal RNA operon,
encoding 5.8S, 18S, and 28S ribosomal subunit genes, and the ITS1
and ITS2 are the most reliable and frequently used biomarkers for
fungal identiﬁcation. They offer the highest probability of
successful identiﬁcation, as well as the broadest range of fungal
detection by sequencing.1,4
Broad-range PCR can be used in fresh, formalin-ﬁxed, and
parafﬁn-embedded tissues, and is particularly useful when
conventional cultures are negative. The fungal primer sequences
used in our case have been reported as very speciﬁc for fungal
pathogens preventing cross-priming with human DNA, however,
sample contamination with commensal or environmental fungi
may lead to false positive results, requiring a careful and judicious
clinical interpretation of results.1 Molecular testing has been
suggested as alternative for the diagnosis of Blastomyces infections
both from cultured organisms and from tissue samples to aid in an
early diagnosis.5
Other diagnostic modalities were used in attempting to reach a
prompt diagnosis in our patient but had several limitations.
Although fungal culture still remains the gold-standard diagnostic
test, growth of the organism is slow, limiting its value for early
diagnosis. In our patient, a deﬁnitive diagnosis was reached by
means of traditional culture techniques, twenty days after his
initial surgery.
As observed in our patient, serology testing also has major
disadvantages in making the diagnosis of blastomycosis. While
immunodiffusion methods that measure antibodies to the
Blastomyces dermatitidis antigen are relatively speciﬁc, sensitivity
is poor. Blastomyces dermatitidis antibodies have also been shown
to cross-react with species of Coccidioides, Histoplasma, Paracocci-
dioides, Penicillium, Aspergillus, and Cryptococcus. Results from
these tests must, therefore, be interpreted in light of the clinical
presentation.
In conclusion, due to its inherent slow growth in vitro, relying
on culture techniques for identiﬁcation of Blastomyces dermatitidis
can potentially delay diagnosis and treatment. Molecular diag-
nostics are, therefore, a powerful tool to assist in the identiﬁcation
of invasive fungal infections directly from tissues and may
facilitate providing targeted antifungal therapy in a timely manner.
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